A Phase II Study of Intrathecal I131-3F8 in Patients with GD2-Expressing Central Nervous System and Leptomeningeal Neoplasms
[Protocol 05-122] |
Kramer, Kim |
- Brain Tumors, Metastatic
- Brain Tumors, Primary
- Neuroblastoma
- Pediatric Brain Tumors
|
A Phase II Study of Ipilimumab after Completion of Chemotherapy in Women with Recurrent Platinum-Sensitive Ovarian Cancer with Measurable Residual Disease
[Protocol 12-152] |
Grisham, Rachel |
|
A Phase II Study of Ipilimumab in Children and Adolescents with Stage III/IV Inoperable Melanoma
[Protocol 13-043] |
Dunkel, Ira |
|
A Phase II Study of Ipilimumab Plus Isolated Limb Infusion with Melphalan and Dactinomycin to Treat Advanced Unresectable Melanoma of the Extremity
[Protocol 10-101] |
Ariyan, Charlotte |
|
A Phase II Study of Ipilimumab versus Standard Chemotherapy after Initial Therapy in Patients with Inoperable or Advanced Gastric or Gastroesophageal Cancer
[Protocol 12-277] |
Ku, Geoffrey |
- Upper Gastrointestinal
- Esophageal Cancer
- Gastric Cancer
|
A Phase II Study of IZN-6N4 to Reduce Mouth Sores in Patients with Head and Neck Cancer Receiving Chemotherapy and Radiation Therapy
[Protocol 12-204] |
Lee, Nancy |
|
A Phase II Study of KW-0761 or Standard Therapy in Patients with Previously Treated Adult T-Cell Leukemia-Lymphoma
[Protocol 12-251] |
Horwitz, Steven |
|
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] |
Hassoun, Hani |
|
A Phase II Study of Maribavir to Treat Resistant Cytomegalovirus Infection in Transplant Recipients
[Protocol 12-281] |
Papanicolaou, Genovefa |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
|
A Phase II Study of mFOLFOX6 with Bevacizumab or Tivozanib in Patients with Metastatic Colorectal Cancer
[Protocol 12-066] |
Cercek, Andrea |
|
A Phase II Study of MK-2206 in Patients with Progressive, Recurrent/Metastatic Adenoid Cystic Carcinoma
[Protocol 11-193] |
Ho, Alan |
|
A Phase II Study of MK-2206 in Patients with Recurrent or Advanced Endometrial Cancer Stratified by PIK3CA Mutation Status
[Protocol 11-071] |
Makker, Vicky |
- Endometrial and other Uterine Cancers
|
A Phase II Study of MLN8237 (Alisertib) with Paclitaxel versus Paclitaxel Alone in Women with Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 12-100] |
Tew, William |
|
A Phase II Study of MLN8237 in Advanced or Metastatic Sarcoma
[Protocol 12-194] |
Dickson, Mark |
|
A Phase II Study of MLN8237 in Patients with Advanced Prostate Cancer
[Protocol 13-042] |
Danila, Daniel |
- Prostate Cancer
- Metastatic Disease after Hormone-Reducing Therapy
|
A Phase II Study of MLN8237 in Patients with Recurrent or Persistent Uterine Leiomyosarcoma
[Protocol 12-164] |
Hyman, David |
- Endometrial and other Uterine Cancers
- Leiomyosarcoma
- Uterine Cancer
- Leiomyosarcoma
- Sarcomas
- Leiomyosarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of MLN8237 in Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
[Protocol 12-096] |
Horwitz, Steven |
|
A Phase II Study of Neoadjuvant Dose-Dense Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
[Protocol 12-071] |
Bajorin, Dean |
|
A Phase II Study of Neoadjuvant Pemetrexed Plus Cisplatin for Patients with Resectable Non-Squamous Non-Small Cell Lung Cancer with "Switch Chemotherapy Alternative" in Non-Responders (NEOSCAN)
[Protocol 11-106] |
Chaft, Jamie |
- Lung Cancer
- Lung Cancer, Non-Small Cell
|
A Phase II Study of New Treatment Approaches for High-Risk Renal Tumors
[Protocol 12-026] |
Kobos, Rachel |
|
